Literature DB >> 31357373

Quartz crystal microbalance biosensor for label-free MDA MB 231 cancer cell detection via notch-4 receptor.

Monireh Bakhshpour1, Ayse Kevser Piskin2, Handan Yavuz1, Adil Denizli3.   

Abstract

Breast cancer is the most common cancer in women with increasing insidance. Breast cancer occurs as a result of some molecular changes, such as aberrant or dysregulated expression of receptors, in breast epithelial cells. Therefore, breast cancer cells can be detected through their membrane receptors using specific antibodies. This study aims to form a quartz crystal microbalance (QCM) biosensor to detect breast cancer cells. Notch receptor signaling directs many pathways in developing breast tissue and its expression is found to be aberrant or disregulated in metastatic breast cancer cells. Its involvement in malignant transformation makes it a potential drug target. The human metastatic breast cancer cells, MDA MB 231 cells, are used here as a model due to the overexpression of notch-4 receptor on their membranes. First, to increase the surface area of the chip poly(2-hydroxyethyl methacrylate-PHEMA) nanoparticles were synthesized and were placed on QCM chip surface. Then, the surface was further modified and functionalized by binding notch-4 receptor antibody using carbodiimide. Nanoparticle coated and antibody attached QCM chips were characterized via FTIR-ATR, ellipsometry, contact angle measurements and by atomic force microscopy. MDA MB 231 cell samples ranging in numbers between 50-300 cells/ml were introduced to the functionalized QCM chip at a flow rate of 1.0 mL/min and the resonance frequency (f0) was recorded. Then, cell samples were applied to the QCM biosensor and the resonance frequency was monitored. The binding mode fitted best to Langmuir isotherm model. Sensitivity is found to be high and the selectivity as tested by competitive adsorption of L929 mouse fibroblast cells showed that QCM biosensor was 17.5 times more selective for MDA MB 231 cells than the fibroblast cells. The chip was reusable and was stable over 3 months. These results indicate that, the notch-4 receptor antibody PHEMA nanoparticle QCM biosensor is highly selective and efficient system that may be used for cancer cell detection.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Biosensor; Breast cancer; Nanoparticle; Notch-4 receptor; Quartz crystal microbalance

Year:  2019        PMID: 31357373     DOI: 10.1016/j.talanta.2019.06.060

Source DB:  PubMed          Journal:  Talanta        ISSN: 0039-9140            Impact factor:   6.057


  6 in total

1.  Sensors and Biosensors in Organs-on-a-Chip Platforms.

Authors:  Gerardo A Lopez-Muñoz; Sheeza Mughal; Javier Ramón-Azcón
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 3.650

Review 2.  Acoustic Biosensors and Microfluidic Devices in the Decennium: Principles and Applications.

Authors:  Minu Prabhachandran Nair; Adrian J T Teo; King Ho Holden Li
Journal:  Micromachines (Basel)       Date:  2021-12-26       Impact factor: 2.891

3.  Uniform Mass Sensitivity Distribution of Elliptically Designed Electrodes Based on a Quartz Crystal Microbalance.

Authors:  Haifeng Jiang; Longfei Tang
Journal:  ACS Omega       Date:  2021-11-23

4.  New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer.

Authors:  K R Hossain; J D Escobar Bermeo; K Warton; S M Valenzuela
Journal:  Front Bioeng Biotechnol       Date:  2022-02-10

5.  A Microfluidic Biosensor Based on Magnetic Nanoparticle Separation, Quantum Dots Labeling and MnO2 Nanoflower Amplification for Rapid and Sensitive Detection of Salmonella Typhimurium.

Authors:  Li Hao; Li Xue; Fengchun Huang; Gaozhe Cai; Wuzhen Qi; Miao Zhang; Qing'an Han; Zengli Wang; Jianhan Lin
Journal:  Micromachines (Basel)       Date:  2020-03-09       Impact factor: 2.891

Review 6.  A Review of Biosensors for Detecting Tumor Markers in Breast Cancer.

Authors:  Rui Hong; Hongyu Sun; Dujuan Li; Weihuang Yang; Kai Fan; Chaoran Liu; Linxi Dong; Gaofeng Wang
Journal:  Life (Basel)       Date:  2022-02-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.